Articles with public access mandates - Laura MageeLearn more
Not available anywhere: 23
Sildenafil citrate therapy for severe early‐onset intrauterine growth restriction
P Von Dadelszen, S Dwinnell, LA Magee, BC Carleton, A Gruslin, B Lee, ...
BJOG: An International Journal of Obstetrics & Gynaecology 118 (5), 624-628, 2011
Mandates: Canadian Institutes of Health Research
An international trial of antioxidants in the prevention of preeclampsia (INTAPP)
H Xu, R Perez-Cuevas, X Xiong, H Reyes, C Roy, P Julien, G Smith, ...
American journal of obstetrics and gynecology 202 (3), 239. e1-239. e10, 2010
Mandates: Canadian Institutes of Health Research
Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?
SJ Benton, Y Hu, F Xie, K Kupfer, SW Lee, LA Magee, P von Dadelszen
American journal of obstetrics and gynecology 206 (2), 163. e1-163. e7, 2012
Mandates: Canadian Institutes of Health Research
Pre-eclampsia: an update
P von Dadelszen, LA Magee
Current hypertension reports 16 (8), 454, 2014
Mandates: Canadian Institutes of Health Research
Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial
LA Magee, CHIPS Study Group, P von Dadelszen, J Singer, T Lee, E Rey, ...
BJOG: An International Journal of Obstetrics & Gynaecology 123 (7), 1143-1151, 2016
Mandates: Canadian Institutes of Health Research
Toll‐like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre‐eclampsia
F Xie, Y Hu, SE Turvey, LA Magee, RM Brunham, KC Choi, M Krajden, ...
BJOG: An International Journal of Obstetrics & Gynaecology 117 (1), 99-108, 2010
Mandates: Canadian Institutes of Health Research
What matters in preeclampsia are the associated adverse outcomes: the view from Canada
P von Dadelszen, L Magee
Current opinion in obstetrics and gynecology 20 (2), 110-115, 2008
Mandates: Canadian Institutes of Health Research
Performance of the fullPIERS model in predicting adverse maternal outcomes in pre‐eclampsia using patient data from the PIERS (Pre‐eclampsia Integrated Estimate of RiSk) cohort …
B Payne, S Hodgson, JA Hutcheon, KS Joseph, J Li, T Lee, LA Magee, ...
BJOG: An International Journal of Obstetrics & Gynaecology 120 (1), 113-118, 2013
Mandates: Canadian Institutes of Health Research
The management of severe hypertension
LA Magee, P von Dadelszen
Seminars in perinatology 33 (3), 138-142, 2009
Mandates: Canadian Institutes of Health Research
Toll-like receptor gene polymorphisms and preeclampsia risk: a case-control study and data synthesis
F Xie, Y Hu, DP Speert, SE Turvey, G Peng, DM Money, LA Magee, ...
Hypertension in Pregnancy 29 (4), 390-398, 2010
Mandates: Canadian Institutes of Health Research
Control of Hypertension In Pregnancy Study randomised controlled trial—are the results dependent on the choice of labetalol or methyldopa?
LA Magee, CHIPS Study Group, P Von Dadelszen, J Singer, T Lee, E Rey, ...
BJOG: An International Journal of Obstetrics & Gynaecology 123 (7), 1135-1141, 2016
Mandates: Canadian Institutes of Health Research
Chlamydia pneumoniae Infection in Preeclampsia
F Xie, Y Hu, LA Magee, DM Money, DM Patrick, RM Brunham, E Thomas, ...
Hypertension in Pregnancy 29 (4), 468-477, 2010
Mandates: Canadian Institutes of Health Research
Management of non-severe pregnancy hypertension–A summary of the CHIPS Trial (Control of Hypertension in Pregnancy Study) research publications
LA Magee, E Rey, E Asztalos, E Hutton, J Singer, M Helewa, T Lee, ...
Pregnancy hypertension 18, 156-162, 2019
Mandates: Canadian Institutes of Health Research
An assessment of predictive value of the biophysical profile in women with preeclampsia using data from the fullPIERS database
BA Payne, PM Kyle, K Lim, S Lisonkova, LA Magee, B Pullar, Z Qu, ...
Pregnancy Hypertension: An International Journal of Women's Cardiovascular …, 2013
Mandates: Canadian Institutes of Health Research
Patient preferences and decisional needs when choosing a treatment approach for pregnancy hypertension: a stated preference study
RK Metcalfe, M Harrison, A Hutfield, M Lewisch, J Singer, LA Magee, ...
Canadian Journal of Cardiology 36 (5), 775-779, 2020
Mandates: Canadian Institutes of Health Research, Michael Smith Foundation for Health …
Maternal Risk Modeling in Critical Care—Development of a Multivariable Risk Prediction Model for Death and Prolonged Intensive Care
NB Simpson, M Shankar-Hari, KM Rowan, M Cecconi, P Von Dadelszen, ...
Critical Care Medicine 48 (5), 663-672, 2020
Mandates: National Institute for Health Research, UK
Microalbuminuria and the hypertensive disorders of pregnancy
AM Côté, P Dadelszen, JM Moutquin, JL Ardilouze, LA Magee
Current Hypertension Reviews 6 (1), 8-19, 2010
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Pseudotumor cerebri syndrome with different types of hormonal contraceptives in women of child‐bearing age
M Etminan, F Khosrow‐Khavar, M Sodhi, B Carleton, LA Magee, ...
European Journal of Neurology 27 (12), 2625-2629, 2020
Mandates: Canadian Institutes of Health Research
5.6 The Control of Hypertension In Pregnancy Study (CHIPS) randomised controlled trial
LA Magee, P von Dadelszen, E Rey, S Ross, E Asztalos, K Murphy, ...
Archives of Disease in Childhood-Fetal and Neonatal Edition 99 (Suppl 1), A5-A6, 2014
Mandates: Canadian Institutes of Health Research
Authors' reply re: Maternity services in the UK during the coronavirus disease 2019 pandemic: a national survey of modifications to standard care.
S Relph, J Jardine, LA Magee, P Dadelszen, E Morris, M Ross‐Davie, ...
BJOG: An International Journal of Obstetrics & Gynaecology 128 (5), 2021
Mandates: National Institute for Health Research, UK
Publication and funding information is determined automatically by a computer program